4//SEC Filing
Pauls Dietrich John 4
Accession 0001235802-24-000050
CIK 0001401040other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 4:41 PM ET
Size
6.5 KB
Accession
0001235802-24-000050
Insider Transaction Report
Form 4
Pauls Dietrich John
DirectorPresident & CEO
Transactions
- Award
Stock Option (right to buy)
2024-06-01+300,000→ 300,000 totalExercise: $2.90Exp: 2034-05-31→ Common Shares (300,000 underlying)
Holdings
- 68,591
Voting Common Shares, no par value per share
Footnotes (2)
- [F1]Includes 1,749 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.
- [F2]Vests with respect to 25% of the underlying common shares on June 1, 2025 and with respect to the remaining 75% of the underlying common shares vesting quarterly over the following three years commencing on September 1, 2025.
Documents
Issuer
DiaMedica Therapeutics Inc.
CIK 0001401040
Entity typeother
Related Parties
1- filerCIK 0001760123
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 4:41 PM ET
- Size
- 6.5 KB